Noncoding RNAs in age-related cardiovascular diseases
(opens in new window)
Author(s):
Amela Jusic, Pınar Buket Thomas, Stephanie Bezzina Wettinger, Soner Dogan, Rosienne Farrugia, Carlo Gaetano, Bilge Güvenç Tuna, Florence Pinet, Emma L. Robinson, SimonTual-Chalot, Konstantinos Stellos, Yvan Devaux, On behalf of EU-CardioRNA COST Action CA17129
Published in:
Ageing Research Reviews, Issue Volume 77, 2022, Page(s) 101610, ISSN 1568-1637
Publisher:
Elsevier BV
DOI:
10.1016/j.arr.2022.101610
(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19
(opens in new window)
Author(s):
Amela Jusic, Konstantinos Stellos, Lino Ferreira, Andrew H.Baker, Yvan Devaux
Published in:
Journal of Molecular and Cellular Cardiology Plus, Issue Volume 1, September 2022, 100013, 2022, ISSN 2772-9761
Publisher:
Science Direct
DOI:
10.1016/j.jmccpl.2022.100013
Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129
(opens in new window)
Author(s):
Lina Badimon, Emma L Robinson, Amela Jusic, Irina Carpusca, Leon J deWindt, Costanza Emanueli, Péter Ferdinandy, Wei Gu, Mariann Gyöngyösi, Matthias Hackl, Kanita Karaduzovic-Hadziabdic, Mitja Lustrek, Fabio Martelli, Eric Nham, Ines Potočnjak, Venkata Satagopam, Reinhard Schneider, Thomas Thum, and Yvan Devaux, on behalf of EU-CardioRNA COST Action CA17129
Published in:
Cardiovascular Research, Issue Volume 117, Issue 8, 2021, Page(s) 1823–1840, ISSN 1755-3245
Publisher:
Oxford University Press
DOI:
10.1093/cvr/cvab094
